RxDoctor Payments Data

Timothy Williams, MD

Family Medicine · Metamora, ILNPI 1508893595

Payments from drug & device makers

$941in general payments, 2019–2025

Across 55 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$192
  • Amgen$108
  • Lilly USA, LLC$94
  • AstraZeneca$84
  • Boehringer Ingelheim$69
  • Abbott$66
  • plus $329 from 12 others

What the payments were for

  • Food & beverage$941100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$941 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$105,332
Medicare patients
451
Services billed
1,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide142$157,645
EliquisApixaban155$142,517
JardianceEmpagliflozin85$67,491
FarxigaDapagliflozin Propanediol46$51,512
XareltoRivaroxaban41$50,451
RybelsusSemaglutide39$48,576
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$23,139
MounjaroTirzepatide17$22,169
Spiriva RespimatTiotropium Bromide35$20,747
VivitrolNaltrexone Microspheres13$20,454
DapagliflozinDapagliflozin Propanediol14$20,448
Bydureon BciseExenatide Microspheres17$20,427
TrulicityDulaglutide22$18,903
LinzessLinaclotide13$17,088
Serevent DiskusSalmeterol Xinafoate20$15,686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$192$206,221181 claims
PfizerEliquis$26$142,517155 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$69$94,891134 claims
AstraZenecaFarxiga$84$51,51246 claims
Lilly USA, LLCMounjaro, Trulicity$94$41,07239 claims
GSKTrelegy Ellipta$45$23,13937 claims
AbbVieLinzess$15$17,08813 claims
Astellas Pharma US IncMyrbetriq$18$15,18618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Metamora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →